Skip to main content

Table 4 Comparison of treatment outcomes between specific drug-containing regimens by drug-resistance pattern (MDR- VS- pre-XDR TB)

From: Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres

 

MDR-TB

Pre-XDR TB

p-value

Clofazimine-containing regimens

n = 8

n = 17

 

Treatment outcome, n (%)

Cured

5 (62.5)

7 (41.2)

0.41

Treatment completed

2 (25.0)

6 (35.3)

1.0

Died

1 (12.5)

3 (17.7)

1.0

Default

–

1 (5.9)

1.0

Transferred out

–

–

–

Treatment success

7 (87.5)

13 (76.5)

1.0

Linezolid-containing regimens

n = 23

n = 23

 

Treatment outcome, n (%)

Cured

17 (73.9)

12 (52.2)

0.22

Treatment completed

3 (13.0)

8 (34.8)

0.17

Died

1 (4.4)

3 (13.0)

0.61

Default

1 (4.4)

–

1.0

Transferred out

1 (4.4)

–

1.0

Treatment success

20 (87.0)

20 (87.0)

1.0

Meropenem-containing regimens

n = 22

n = 23

 

Treatment outcome, n (%)

Cured

20 (90.9)

12 (52.2)

0.007

Treatment completed

0 (0.0)

8 (34.8)

0.004

Died

2 (9.1)

3 (13.0)

1.0

Default

–

–

 

Transferred out

–

–

 

Treatment success

20 (90.9)

20 (87.0)

1.0

Fluoroquinolones-containing regimens

n = 88

n = 31

 

Treatment outcome, n (%)

Cured

39 (44.3)

13 (41.9)

0.82

Treatment completed

33 (37.5)

11 (35.5)

0.84

Died

3 (3.4)

3 (9.7)

0.18

Default

9 (10.2)

1 (3.2)

0.45

Transferred out

4 (4.6)

3 (9.7)

0.38

Treatment success

72 (81.8)

24 (77.4)

0.59

Amikacin-containing regimens

n = 43

n = 22

 

Treatment outcome, n (%)

Cured

28 (65.1)

8 (36.4)

0.03

Treatment completed

11 (25.6)

10 (45.5)

0.11

Died

2 (4.7)

2 (9.1)

0.60

Default

1 (2.3)

–

1.0

Transferred out

1 (2.3)

2 (9.1)

0.26

Treatment success

39 (90.7)

18 (81.8)

0.43